Functional Activity Strength Training
- Conditions
- Walking, Difficulty
- Interventions
- Behavioral: Daily exercise intervention
- Registration Number
- NCT05697497
- Lead Sponsor
- Milton S. Hershey Medical Center
- Brief Summary
This study is a randomized trial of 100 older adults with mobility disability, who performed a similar brief daily, resistance training program. The investigators set out to answer the following question "Will a digital, brief daily exercise program be feasible, acceptable, and effective among older adults with walking limitations?" To answer that question, participants were assigned to an intervention or delayed-treatment control group. Intervention participants were assigned to complete two 30-second lower body exercises and two 30-second upper body exercises. Fitness tests were completed remotely three times during the 12-weeks (i.e., at baseline, week 6, week 12).
- Detailed Description
This is a 12-week delayed-control randomized trial to answer the following question "Will a digital, brief daily exercise program be feasible, acceptable, and effective among older adults with walking limitations?" Participants who screen eligible will be assigned to one of four conditions, an immediate workout group, an immediate workout group with activity monitor, a delayed workout group or a delayed workout group with activity monitor. Participants will complete a daily 2.5-to-3.5-minute exercise routine at home and to record their results using an electronic survey. Other outcome measurements will be conducted remotely at baseline, 6, and 12 weeks.
The investigators hypothesize that participants in the AMRAP condition will report significant reductions in functional physical limitations, increased gait speed, and increased physical performance (i.e., increased exercise repetitions) from baseline to 6 weeks compared to those randomized to the delayed-treatment control.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 101
- Age 65 and older
- Difficulty with walking
- Providers must provide consent for their patient
- Access to the internet
- Must have a camera on computer, tablet, or smartphone
- Fluent in Egnlish
- Chest pain or a heart condition on the PAR-Q
- Planning to have surgery in the next 3 months
- Cognitive impairment
- Unable to exercise
- Being currently physically active
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Immediate start group without gait cadence assessment Daily exercise intervention The exercise intervention consists of a 2.5 to 3.5 minute daily routine that includes 2 upper body and 2 lower body exercises. Immediate start group with gait cadence assessment Daily exercise intervention This group will wear an activPAL device for 10 days prior to their baseline assessment and for 10 days after their week 12 assessment. The exercise intervention consists of a 2.5 to 3.5 minute daily routine that includes 2 upper body and 2 lower body exercises.
- Primary Outcome Measures
Name Time Method 30-Second Chair Stand 12 weeks Leg strength and endurance test - number of chair stand repetitions in 30 seconds
Single Leg Stance Test (SLS) 12 weeks Assessment of static postural and balance control.
Falls 12 weeks Falls over the past 3 months will be assessed using the Behavioral Risk Factor Surveillance System survey.
Five Time Sit to Stand Test (5TSTS) 12 weeks The Five Times Sit to Stand Test measures one aspect of transfer skill. The test provides a method to quantify functional lower extremity strength and/or identify movement strategies a patient uses to complete transitional movements. The score is the amount of time (to the nearest decimal in seconds) it takes a patient to transfer from a seated to a standing position and back to sitting five times.
Functional limitations 12 weeks Physical Functioning Questionnaire from the National Health and Nutrition Examination Survey
- Secondary Outcome Measures
Name Time Method Pain on the Patient Reported Outcomes Measurement Information System (PROMIS) survey 12 weeks Survey using questions from the NIH-supported Patient Reported Outcomes Measurement Information System (PROMIS). The minimal value for pain interference is not at all, while the minimum value for pain intensity is no pain. The maximum value for pain interference is very much, while the maximum value for pain intensity is worst pain imaginable. A higher score generally means a worse outcome.
Self-Efficay for Physical Activity (SEPA) 12 weeks 5-item measure that assesses an individual's confidence for engaging in exercise in the presence of barriers.
Walking gait cadence 10 day period pre and post intervention Gait cadence will be measured in 50% of the participants using an activPAL device.
Fatigue on the Patient Reported Outcomes Measurement Information System (PROMIS) survey 12 weeks Survey using questions from the NIH-supported Patient Reported Outcomes Measurement Information System (PROMIS). The minimum value for fatigue is not at all, while the maximum value is very much. A higher score generally means a worse outcome.
Percent of sessions attended 12 weeks Patients will be considered adherent to the intervention when they enter their daily exercise performance data via daily survey. The percent of sessions attended will be calculated by dividing the number of sessions attended by the total number of sessions offered and multiplying the result by 100.
Heart rate 12 weeks resting and maximal heart rates will be collected during the maximal exercise performance tests
Trial Locations
- Locations (1)
Penn State Hershey Medical Center
🇺🇸Hershey, Pennsylvania, United States